The global anal fissure treatment market is expected to acquire significant revenue by 2031 and grow with a CAGR of around 7% during 2022-2031; Increase in Geriatric and Pediatric Constipation Patients to Accelerate Market Growth – Kenneth Research
Key companies profiled in the Global Anal Fissures Treatment Market research report by Kenneth Research include AstraZeneca, SLA Pharma AG, Eisai Co., Ltd., Bayer AG, Novasep, Ipsen Pharma, Cipla Inc., SRS Life Sciences , Healthy Life Pharma Private Limited , Geri-Care Pharmaceuticals Corp., and others.
New York, Oct. 21, 2022 (GLOBE NEWSWIRE) — Kenneth Research has released a detailed market report on the “Global Anal Fissures Treatment Market” for the forecast period, i.e. 2023-2031 which includes the following factors:
Market Growth Over the Forecast Period
Detailed regional synopsis
Major market players and their detailed profiling
Global Anal Fissures Treatment Market Size
The global Anal Fissure Treatment market is anticipated to acquire significant revenue by 2031 and rising at a CAGR of around 7% during the forecast period. The market is expected to grow due to the growing number of elderly and pediatric patients who regularly suffer from constipation. United Nations data shows that the elderly population is expected to grow at the fastest rate of all age groups, from over 10% in 2019 to over 15% by 2031.
Anal fissures, which cause anal fissures, affect nearly 10 in every 100,000 people, making them relatively common. It is a rupture of the mucous membrane, a thin layer of moist tissue that lines the anus. Constipation is one of the main effects of a diet low in fruits and vegetables. Dehydration, stress, insufficient exercise, certain medications (strong painkillers, antidepressants), and other life activities that ignore the need to perform a bowl motion can all contribute to chronic constipation. The World Health Organization (WHO) estimates that one in four people do not meet daily physical activity recommendations.
Get a sample copy of this report @ https://www.kennethresearch.com/sample-request-10082826
Global Anal Fissures Treatment Market: Key Takeaways
The North American region gets most of the revenue.
The oral segment to influence the revenue graph.
The hospital pharmacy segment retains a significant presence in the market.
Increase in constipation rate and advancements in medical technology to drive market growth
Anal fissures can tear and grow from straining during bowel movements and passing firm stools. Episodes of constipation are more frequent in patients who have already experienced it. According to a study by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 33 out of 100 people aged 60 and over suffer from constipation, compared to 16 out of 100 adults who suffer from constipation on average.
In addition, the anal fissure treatment market has expanded through the use of anoscopy, sigmoidoscopy and colonoscopy for the diagnosis of anal fissures and the increasing use of laser in the treatment. The muscles surrounding the anus are sliced or pulled in a surgical operation called a lateral internal sphincterotomy (LIS) which treats the fissure. The number of colonoscopies performed each year in the United States is thought to be approximately 17 million.
Global Anal Fissures Treatment Market: Regional Synopsis
The global anal fissure treatment market is segmented into five major regions including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Navigate to access in-depth research report on Global Anal Fissure Treatment Market with in-depth charts and figures: https://www.kennethresearch.com/report-details/anal-fissure-treatment-market/10082826
Growing Geriatric Population and Increase in Sedentary Lifestyles to Supply the North American Market
Due to its expanding elderly population, North America is expected to hold the largest share of the market by the end of 2031. The Administration for Community Living estimates that the percentage of Americans 65 and older will increase to 21.6% by 2040 from 16% in 2019. Other factors driving the expansion of the market include adoption of sedentary lifestyle and increase in fat consumption saturated and trans. Worldwide, 28% of adults or 1.4 billion people lead a sedentary lifestyle, or more than 1 in 4 adults.
Rise in Generic Manufacturers and Rise in Healthcare Spending to Drive Asia-Pacific Market
Due to the presence of several generic manufacturers, technical improvements with new products introduced every year by the pharmaceutical and biotech industries, Asia-Pacific has the fastest growing market. According to the National Investment Promotion and Facilitation Agency, Indian pharmaceutical companies have produced more than 60,000 generic brands covering 60 therapeutic areas, including generic drugs, over-the-counter drugs, API/bulk drugs and others . Additionally, rising healthcare expenditure in the region is further bolstering the growth of the market. For example, healthcare spending in China was 5.35% in 2019, compared to 5.07 in 2017.
Get Sample PDF of Global Anal Fissures Treatment Market @ https://www.kennethresearch.com/sample-request-10082826
The study further incorporates annual growth, demand and supply, and forecasts future opportunities in:
North America (USA, Canada)
Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands and Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark]Poland, Turkey Russia, Rest of Europe)
Latin America (Brazil, Mexico Argentina, Rest of Latin America)
Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman]North Africa, South Africa, Rest of the Middle East and Africa)
Global Anal Fissure Treatment Market Segmentation by Route of Administration
The oral segment is expected to have the highest market share by the end of 2031. Laxatives, calcium channel blockers, analgesics, and stool softeners are few of the oral medications. Botulinum toxin A and nitroglycerin are some of the topical medications. As majority of these pharmaceuticals are freely available over-the-counter, the oral treatment segment holds the highest market share. Laxatives are often used to treat childhood constipation. More than 3% of children worldwide suffer from functional constipation, while a 10 to 23% prevalence is expected in North and South America.
Access full report description, table of contents, table of figure, graph, etc. @ https://www.kennethresearch.com/sample-request-10082826
Global Anal Fissures Treatment Market, Segmentation by Distribution Channel
The hospital pharmacy segment is anticipated to hold a major market share during the forecast period. Hospital pharmacies are the essential component of hospitals and are responsible for a notable part of their profits. The number of hospital pharmacies increases with the number of hospitals. For example, the number of hospitals in the United States was 6,095, the number in Japan was 8,240, and the number in Colombia was 10,900 in 2020.
Global Anal Fissures Treatment Market Segmentation by Treatment Type
Global Anal Fissures Treatment Market, Segmentation by End User
A few of the global anal fissure treatment market leaders that are profiled by Kenneth Research include AstraZeneca, SLA Pharma AG, Eisai Co., Ltd., Bayer AG, Novasep, Ipsen Pharma, Cipla Inc., SRS Life Sciences, Healthy Life Pharma Private Limited, Geri-Care Pharmaceuticals Corp. and others.
Do you have a specific question or requirement? Ask our expert: https://www.kennethresearch.com/sample-request-10082826
Recent Developments in the Global Anal Fissure Treatment Market
January 15the,2021, Ipsen reported that in 5 therapeutic indications, a significant fraction of patients treated with its Dysport (abobotulinumtoxinA) did not require retreatment.
May 20e,2022, MOVICOL HD, a drug to treat chronic constipation, was introduced in Japan by Eisai Co., Ltd., and Mochida Pharmaceutical Co., Ltd., Adults and children 2 years and older are prescribed for l ‘utilize.
Browse more related reports:
Global Heart Rate Monitor Market Analysis by type [Wearable (Chest Strap, Wrist Strap, Strapless), and Non-Wearable]; by Indication (Sport and Medical); and by end user (hospitals and clinics, sports medicine centers, professionals and individuals) – Analysis of supply and demand and outlook for opportunities 2023-2033
Global Cardiovascular Applications Market Analysis by type of device (diagnostic and monitoring devices and surgical devices); by application (cardiac arrhythmia, coronary artery disease and heart failure); and by End User (Hospitals, Cardiac Care Centers, Ambulatory Centers, and Home and University Care Centers) – Supply & Demand Analysis and Opportunity Outlook 2023-2033
Vital Signs Monitoring Equipment Market Segmentation by product type (pulse oximeters, blood pressure monitoring devices, temperature monitoring devices); by End User (Hospitals, Ambulatory Surgery Centers, Clinics, Home Care and Others) – Global Demand Analysis and Opportunity Outlook 2030
Global epilepsy market Segmentation by end use (diagnostic centers, hospitals, clinics, outpatient surgery centers and others); and by Treatment & Diagnostics (Treatment & Diagnostics) – Global Demand Analysis and Opportunity Outlook 2031
Cardiac implant market Analysis by application (congestive heart failure, myocardial ischemia, arrhythmias and acute myocardial infraction); by end users (specialty clinics, hospitals, ambulatory surgery centers and others); and by Device Type (Cardiac Value, Pacifiers, Coronary Stents, Ventricular Assist Devices and Others) – Global Supply & Demand Analysis and Opportunity Outlook 2022-2031
About Kenneth Research
Kenneth Research is a leading provider of strategic market research and consulting services. Our aim is to provide unbiased and unparalleled market intelligence and industry analysis to help industries, conglomerates and executives make sound decisions for their future marketing strategy, expansion and investments etc. at the right time is available thanks to strategic minds. Our original thinking helps our clients make sound decisions to avoid future uncertainties.
Contact for more information:
Email: [email protected]
Telephone in the United States: +1 313 462 0609
The Web: https://www.kennethresearch.com/